Prefrontal GABA(B) receptor activation attenuates phencyclidine-induced impairments of prepulse inhibition: Involvement of nitric oxide

Neuropsychopharmacology

Volumn 34, Issue 7, 2009, Pages 1673-1684

  Fejgin, Kim ^a   Pålsson, Erik ^a,b   Wass, Caroline ^a   Finnerty, Niall ^b   Lowry, John ^b   Klamer, Daniel ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Baclofen; GABA B; Phencyclidine; Prefrontal cortex; Prepulse inhibition; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

ACOUSTIC STIMULATION; ANIMALS; BACLOFEN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ELECTROCHEMISTRY; ENZYME INHIBITORS; GABA AGONISTS; MALE; MICE; MICE, INBRED STRAINS; NEURAL INHIBITION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENCYCLIDINE; PREFRONTAL CORTEX; RECEPTORS, GABA-B; SIGNAL TRANSDUCTION; STARTLE REACTION;

EID: 67349094027     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.225     Document Type: Article

References (90)

1. Adams B, Moghaddam B (1998). Corticolimbic dopamine neuro-transmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18: 5545-5554.
2. Ahlenius S, Carlsson A, Engel J (1975). Antagonism by baclophen of the d-amphetamine-induced disruption of a successive discrimination in the rat. J Neural Transm 36: 327-333.
3. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney Jr WE et al (1995). Gene expression for glutamic acid decarbox-ylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52: 258-266.
4. Arai S, Takuma K, Mizoguchi H, Ibi D, Nagai T, Takahashi K et al (2008). Involvement of pallidotegmental neurons in metham-phetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABA(B) receptor agonist baclofen. Neuropsychopharmacology 33: 3164-3175.
5. Beckmann H, Frische M, Ruther E, Zimmer R (1977). Baclofen (para-chlorphenyl-GABA) in schizophrenia. Pharmakopsychiatr Neuropsychopharmakol 10: 26-31.
6. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL et al (2007). Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318: 1645-1647.
7. Benes FM (1999). Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol Psychiatry 46: 589-599.
8. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL (1991). Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48: 996-1001.
9. Benes FM, Vincent SL, Todtenkopf M (2001). The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 50: 395-406.
10. Bettler B, Kaupmann K, Mosbacher J, Gassmann M (2004). Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev 84: 835-867.
11. Bigelow LB, Nasrallah H, Carman J, Gillin JC, Wyatt RJ (1977). Baclofen treatment in chronic schizophrenia: a clinical trial. Am J Psychiatry 134: 318-320.
12. Bortolato M, Frau R, Aru GN, Orru M, Gessa GL (2004). Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomor-phine. Psychopharmacology (Berl) 171: 322-330.
13. Bortolato M, Frau R, Orru M, Piras AP, Fa M, Tuveri A et al (2007). Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice. Psychopharmacology (Berl) 194: 361-369.
14. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997). Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154: 805-811.
15. Brown FO, Finnerty NJ, Bolger FB, Millar J, Lowry JP (2005). Calibration of NO sensors for in-vivo voltammetry: laboratory synthesis of NO and the use of UV-visible spectroscopy for determining stock concentrations. Anal Bioanal Chem 381: 964-971.
16. Brown FO, Lowry JP (2003). Microelectrochemical sensors for in vivo brain analysis: an investigation of procedures for modifying Pt electrodes using Nafion. Analyst 128: 700-705.
17. Catafau AM, Parellada E, Lomena FJ, Bernardo M, Pavia J, Ros D et al (1994). Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. J Nucl Med 35: 935-941.
18. Couve A, Moss SJ, Pangalos MN (2000). GABAB receptors: a new paradigm in G protein signaling. Mol Cell Neurosci 16: 296-312.
19. Cross AJ, Crow TJ, Owen F (1979). Gamma-aminobutyric acid in the brain in schizophrenia. Lancet 1: 560-561.
20. Diederich K, Koch M (2005). Role of the pedunculopontine tegmental nucleus in sensorimotor gating and reward-related behavior in rats. Psychopharmacology (Berl) 179: 402-408.
21. Erhardt S, Andersson B, Nissbrandt H, Engberg G (1998). Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors. Naunyn Schmiedebergs Arch Pharmacol 357: 611-619.
22. Erhardt S, Mathe JM, Chergui K, Engberg G, Svensson TH (2002). GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo. Naunyn Schmiedebergs Arch Pharmacol 365: 173-180.
23. Fedele E, Varnier G, Raiteri M (1997). In vivo microdialysis study of GABA(A) and GABA(B) receptors modulating the glutamate receptor/NO/cyclic GMP pathway in the rat hippocampus. Neuropharmacology 36: 1405-1415.
24. Feenstra MG, Botterblom MH, van Uum JF (2002). Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission. Neuropharmacology 42: 752-763.
25. Fejgin K, Palsson E, Wass C, Svensson L, Klamer D (2008). Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine. Neuropsychopharmacology 33: 1874-1883.
26. Fejgin K, Safonov S, Palsson E, Wass C, Engel JA, Svensson L et al (2007). The atypical antipsychotic, aripiprazole, blocks phency-clidine-induced disruption of prepulse inhibition in mice. Psychopharmacology (Berl) 191: 377-385.
27. Finnerty N (2008). Electrochemical Sensors: In-Vitro and In-Vivo Analysis of Brain Nitric Oxide and Regional Cerebral Blood Flow. National University of Ireland Maynooth: Maynooth.
28. Franklin KBJ, Paxinos G (1996). The Mouse Brain in Stereotaxic Coordinates. Academic Press: New York.
29. Frederiksen PK (1975). Letter: Baclofen in the treatment of schizophrenia. Lancet 1: 702.
30. Freedman R, Adler LE, Gerhardt GA, Waldo M, Baker N, Rose GM et al (1987). Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull 13: 669-678.
31. Friston KJ, Liddle PF, Frith CD, Hirsch SR, Frackowiak RS (1992). The left medial temporal region and schizophrenia. A PET study. Brain 115(Part 2): 367-382.
32. Gabbott PL, Bacon SJ (1995). Co-localisation of NADPH diaphorase activity and GABA immunoreactivity in local circuit neurones in the medial prefrontal cortex (mPFC) of the rat. Brain Res 699: 321-328.
33. Gozzi A, Large CH, Schwarz A, Bertani S, Crestan V, Bifone A (2008). Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology 33: 1690-1703.
34. Grunze HC, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW et al (1996). NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 16: 2034-2043.
35. Gulmann NC, Bahr B, Andersen B, Eliassen HM (1976). A doubleblind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiatr Scand 54: 287-293.
36. Harte M, O'Connor WT (2005). Evidence for a selective prefrontal cortical GABA(B) receptor-mediated inhibition of glutamate release in the ventral tegmental area: a dual probe microdialysis study in the awake rat. Neuroscience 130: 215-222.
37. Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA (2008). Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 165: 479-489.
38. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z et al (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23: 6315-6326.
39. Homayoun H, Moghaddam B (2007). NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27: 11496-11500.
40. Ingvar DH, Franzen G (1974). Distribution of cerebral activity in chronic schizophrenia. Lancet 2: 1484-1486.
41. Ishikawa M, Mizukami K, Iwakiri M, Asada T (2005). Immuno-histochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci Lett 383: 272-277.
42. Ishizuka Y, Ishida Y, Jin QH, Mitsuyama Y, Kannan H (2000). GABA(A) and GABA(B) receptors modulating basal and footshock-induced nitric oxide releases in rat prefrontal cortex. Brain Res 872: 266-270.
43. Jackson ME, Homayoun H, Moghaddam B (2004). NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci USA 101: 8467-8472.
44. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
45. Jentsch JD, Tran A, Le D, Youngren KD, Roth RH (1997). Subchronic phencyclidine administration reduces mesoprefron-tal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 17: 92-99.
46. Johansson C, Jackson DM, Svensson L (1997). Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology (Berl) 131: 167-173.
47. Jonas P, Racca C, Sakmann B, Seeburg PH, Monyer H (1994). Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12: 1281-1289.
48. Jones RS, Buhl EH (1993). Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation. Neurosci Lett 149: 35-39.
49. Klamer D, Engel JA, Svensson L (2001). The nitric oxide synthase inhibitor, L-NAME, blocks phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology (Berl) 156: 182-186.
50. Klamer D, Engel JA, Svensson L (2004). The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur J Pharmacol 503: 103-107.
51. Klamer D, Engel JA, Svensson L (2005a). Effects of phencyclidine on acoustic startle and prepulse inhibition in neuronal nitric oxide synthase deficient mice. Eur Neuropsychopharmacol 15: 587-590.
52. Klamer D, Palsson E, Fejgin K, Zhang J, Engel JA, Svensson L (2005b). Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition. Psychopharmacology (Berl) 179: 479-488.
53. Koch M, Schnitzler HU (1997). The acoustic startle response in ratsFcircuits mediating evocation, inhibition and potentiation. Behav Brain Res 89: 35-49.
54. Kodsi MH, Swerdlow NR (1997). Regulation of prepulse inhibition by ventral pallidal projections. Brain Res Bull 43: 219-228.
55. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995). Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6: 869-872.
56. Lewis DA, Moghaddam B (2006). Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63: 1372-1376.
57. Linn GS, Negi SS, Gerum SV, Javitt DC (2003). Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology (Berl) 169: 234-239.
58. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S et al (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31: 234-242.
59. Lowry JP, Boutelle MG, Fillenz M (1997). Measurement of brain tissue oxygen at a carbon past electrode can serve as an index of increases in regional cerebral blood flow. J Neurosci Methods 71: 177-182.
60. Luby ED, Cohen BD, Rosenbaum G, Gottlieb LS, Kelly R (1959). Study of a new schizophrenomimetic drug-sernyl. Arch Neurol Psychiatry 81: 363-369.
61. Malaspina D, Harkavy-Friedman J, Corcoran C, Mujica-Parodi L, Printz D, Gorman JM et al (2004). Resting neural activity distinguishes subgroups of schizophrenia patients. Biol Psychiatry 56: 931-937.
62. Mansbach RS, Geyer MA (1989). Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2: 299-308.
63. Menon MK, Clark WG, Vivonia C (1980). Interaction between phencyclidine (PCP) and GABA-ergic drugs: clinical implications. Pharmacol Biochem Behav 12: 113-117.
64. Mizukami K, Ishikawa M, Hidaka S, Iwakiri M, Sasaki M, Iritani S (2002). Immunohistochemical localization of GABAB receptor in the entorhinal cortex and inferior temporal cortex of schizophrenic brain. Prog Neuropsychopharmacol Biol Psychiatry 26: 393-396.
65. Mizukami K, Sasaki M, Ishikawa M, Iwakiri M, Hidaka S, Shiraishi H et al (2000). Immunohistochemical localization of gamma-aminobutyric acid(B) receptor in the hippocampus of subjects with schizophrenia. Neurosci Lett 283: 101-104.
66. Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927.
67. Nevins ME, Nash SA, Beardsley PM (1993). Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice. Psychopharmacology (Berl) 110: 92-96.
68. Palsson E, Fejgin K, Wass C, Engel JA, Svensson L, Klamer D (2007). The amino acid L-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice. Psychopharmacology (Berl) 192: 9-15.
69. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV et al (2007). Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 13: 1102-1107.
70. Paxinos G, Watson C (2005). The Rat Brain in Stereotaxic Coordinates. Academic Press: New York.
71. Paylor R, Crawley JN (1997). Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) 132: 169-180.
72. Perry TL, Kish SJ, Buchanan J, Hansen S (1979). Gammaaminobutyric-acid deficiency in brain of schizophrenic patients. Lancet 1: 237-239.
73. Phillis BD, Ong J, White JM, Bonnielle C (2001). Modification of d-amphetamine-induced responses by baclofen in rats. Psychopharmacology (Berl) 153: 277-284.
74. Santiago M, Machado A, Cano J (1993). In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen. Br J Pharmacol 109: 814-818.
75. Schopf J, Hucker H (1977). Baclofen in the treatment of schizophrenia: a pilot study. Pharmakopsychiatr Neuropsychopharmakol 10: 89-91.
76. Swerdlow NR, Geyer MA, Braff DL (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156: 194-215.
77. Szabadits E, Cserep C, Ludanyi A, Katona I, Gracia-Llanes J, Freund TF et al (2007). Hippocampal GABAergic synapses possess the molecular machinery for retrograde nitric oxide signaling. J Neurosci 27: 8101-8111.
78. Takahashi K, Nagai T, Kamei H, Maeda K, Matsuya T, Arai S et al (2007). Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol Psychiatry 62: 148-157.
79. Tanaka S (2008). Dysfunctional GABAergic inhibition in the prefrontal cortex leading to 'psychotic' hyperactivation. BMC Neurosci 9: 41.
80. Taylor SF, Welsh RC, Chen AC, Velander AJ, Liberzon I (2007). Medial frontal hyperactivity in reality distortion. Biol Psychiatry 61: 1171-1178.
81. Waldmeier PC, Kaupmann K, Urwyler S (2008). Roles of GABA(B) receptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release. J Neural Transm 115: 1401-1411.
82. Wass C, Archer T, Palsson E, Fejgin K, Alexandersson A, Klamer D et al (2006a). Phencyclidine affects memory in a nitric oxide-dependent manner: working and reference memory. Behav Brain Res 174: 49-55.
83. Wass C, Archer T, Palsson E, Fejgin K, Klamer D, Engel JA et al (2006b). Effects of phencyclidine on spatial learning and memory: Nitric oxide-dependent mechanisms. Behav Brain Res 171: 147-153.
84. Wass C, Svensson L, Fejgin K, Palsson E, Archer T, Engel JA et al (2008). Nitric oxide synthase inhibition attenuates phencycli-dine-induced disruption of cognitive flexibility. Pharmacol Biochem Behav 89: 352-359.
85. Woo TU, Walsh JP, Benes FM (2004). Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61: 649-657.
86. Yan XX, Jen LS, Garey LJ (1996). NADPH-diaphorase-positive neurons in primate cerebral cortex colocalize with GABA and calcium-binding proteins. Cereb Cortex 6: 524-529.
87. Yesavage JA, Freman AM (1978). Acute phencyclidine (PCP) intoxication: psychopathology and prognosis. J Clin Psychiatry 39: 664-666.
88. Yin H, Turetsky D, Choi DW, Weiss JH (1994). Cortical neurones with Ca2+ permeable AMPA/kainate channels display distinct receptor immunoreactivity and are GABAergic. Neurobiol Dis 1: 43-49.
89. Zhang Y, Behrens MM, Lisman JE (2008). Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol 100: 959-965.
90. Zhou W, Mailloux AW, Jung BJ, Edmunds Jr HS, McGinty JF (2004). GABAB receptor stimulation decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum. Brain Res 1004: 18-28.